Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zhejiang Haichang Biotechnology Co., Ltd.

Latest From Zhejiang Haichang Biotechnology Co., Ltd.

China mRNA COVID Vaccines Progress As Shanghai Rolls Out First Inhaled Shot

CanSino’s global-first inhaled COVID-19 vaccine is dosed into its first noses in Shanghai, while Zhejiang Haichang, Everest Medicines and Abogen make major progress with their respective mRNA vaccine programs.

China Coronavirus COVID-19

TheOTCLab Launches World’s First Fungal Nail Plaster

Dutch foot-care specialists TheOTCLab launches what it claims to be the world's first fungal nail plaster. 

Health OTC Drugs

Can You Kick It? Yes You Can, With Six New Foot-Care Products In The UK

New OTC medicines for fungal nail infections and verrucas have been launched in the UK by Galderma, Reckitt Benckiser and Vemedia, while new foot-care products have also been introduced by Blistex, Epitact and Dermatonics.

OTC Drugs Launches

France's Supplement Market in 2018: Demand For Probiotics and Natural Alternatives Drives Sales Growth

France's food supplements market enjoyed broad-based growth across key categories in 2018, driven by consumer demand for natural alternatives to conventional medicine. Over the 12 months, Pileje overtook Arkopharma as the dominant player in market, as its leading probiotics brand, Symbiosys, flew off the shelves.

France Market Intelligence
See All

Company Information

  • Industry
  • Biotechnology
UsernamePublicRestriction

Register